Mistake - forgot to subtract non-GT1s, only 77,550.
Updated post: Some calculations from the 2013 Milliman HCV report(link below)
They estimated that 164 million Americans (53%) out of 310 million were covered by commercial insurance.
The express scripts formulary action applies to 25 million, or 15 % of commercial patients or 8% of all Americans. More importantly, the HCV prevalence among commercial patients is only 0.47%. So, the Express scripts would roughly have 117,500 HCV individuals, but only 77,500 would be GT1 patients.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.